April 7, 2010 - A new imaging agent, used in brain positron emission tomography (PET) imaging of ?-amyloid in patients with suspected Alzheimer’s disease (AD) or mild cognitive impairment (MCI), is being evaluated for use in the United States and the European Union.

Avid Radiopharmaceuticals Inc. (Avid) and PETNET Solutions Inc. (PETNET), a wholly-owned subsidiary of Siemens Medical Solutions USA, shipped the first dose shipped from a PETNET Solutions manufacturing facility as part of its collaboration with Avid on Florbetapir F 18 (Florbetapir). The molecular imaging agent is used for PET imaging of ?-amyloid deposits in the brain, a key pathological component of Alzheimer’s disease.

PETNET manufactures Florbetapir at multiple facilities in the United States are expanding production capabilities to support the clinical development of Florbetapir.

Avid’s Florbetapir was the first ?-amyloid imaging compound to enter multi-center, IND clinical studies in the United States, and has now been studied in more than a dozen trials in subjects ranging from cognitively normal individuals to those with Alzheimer’s dementia. A pivotal Phase III registration study which was initiated early last year in the United States is nearing completion, and the compound is currently in additional clinical studies in the European Union, South America, Australia and Asia.

For more information: www.avidrp.com and www.siemens.com/healthcare


Related Content

News | Prostate Cancer

July 30, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

Time July 30, 2024
arrow
News | PET-CT

July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...

Time July 25, 2024
arrow
News | PET-CT

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
News | Nuclear Imaging

June 20, 2024 — GE HealthCare joined the world’s top medical and academic institutions at the Society of Nuclear ...

Time June 20, 2024
arrow
News | PET-CT

June 13, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 13, 2024
arrow
News | SPECT-CT

June 11, 2024 — A newly developed radiotracer can generate high quality and readily interpretable images of cardiac ...

Time June 11, 2024
arrow
News | Artificial Intelligence

May 30, 2024 — Paige, a global leader in end-to-end digital pathology solutions and artificial intelligence (AI) ...

Time May 30, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical ...

Time May 10, 2024
arrow
News | Prostate Cancer

May 2, 2024 — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving the ...

Time May 02, 2024
arrow
News | Proton Therapy

April 29, 2024 — Koneksa, a healthcare technology company pioneering evidence-based digital biomarkers, announced today ...

Time April 29, 2024
arrow
Subscribe Now